The government will no longer provide free universal Covid-19 testing for most of the public from 1 April, as part of its plan for living with the virus. While people can currently still order lateral ...

When the coronavirus pandemic first took hold, trying to get a COVID test was like trying to get Glastonbury tickets. Hard to come by is an understatement. But now, well over a year on, a key part of ...

Only a few years ago the benefits of lateral flow diagnostic tests weren’t widely understood outside of scientific circles. The reason most people came into contact with the technology was through the ...

Jack has a degree in Medical Genetics from the University of Leicester.View full profile Jack has a degree in Medical Genetics from the University of Leicester. As the coronavirus pandemic continues ...

Editor's Note: Article updated with latest information on availability of tests. People faced problems getting hold of the tests last week after a huge surge in demand prompted the Government website ...

Sapphiros today announced a strategic supply and manufacturing option agreement with Roche that will grant exclusive rights to lateral flow technology manufacturing capacity to at least 1 billion ...

A Covid-19 lateral flow test showing a negative result. Routine testing to identify those infected followed by efficient contact tracing, and supported isolation is still the most effective public ...

Scientists and public health experts built the COVID-19 pandemic response on years of experience navigating infectious disease outbreaks. Although lateral flow immunoassays have been central to ...

“It's well known that sensitivity is a major driver of commercial success and value for point-of-care tests,” said Jim Kadushin, Genisphere's Chief Operating Officer. “Genisphere's new process for ...

In this interview, News-Medical talks to Andre Alfaro from nanoComposix (now a Fortis Life Sciences Company) about the possibilities lateral flow assays offer in both the present and potential ...

The United Kingdom government plans to implement mass scale population testing for SARS-CoV-2 infection using Lateral Flow Devices (LFDs), yet the devices' sensitivity is unknown. A study published in ...